Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| BRS0102 | Other Identifier | OnCore | |
| IRB-50877 | Other Identifier | Stanford IRB | |
| NCI-2019-03810 | Registry Identifier | National Cancer Institute Clinical Trials Reporting Program |
Not provided
Not provided
Not provided
Awaiting more funding to build a more stable technology.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
This is a research study of a novel, "breast-dedicated" positron emission tomography (PET) camera with 1 millimeter spatial resolution. The main goal of the study is for the personnel to understand practical and logistical issues with using the camera in the clinic
Primary Objective To obtain initial experience using the novel, breast-dedicated PET camera design in the breast imaging clinic.
Secondary Objectives To understand, given the 10-fold higher sensitivity of this novel camera, how low we can go with administered tracer dose, and, given the >100-fold better volumetric spatial resolution, understand the achievable image quality.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| 18-F FDG Study using Breast-Dedicated PET Camera | Experimental | Breast-Dedicated PET Camera will be used with standard PET 18-F FDG tracer dose |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| 18F-FDG | Drug | Participant will be injected IV (intravenously) with 10 ± 2 mCi of 18F-FDG. |
|
| Measure | Description | Time Frame |
|---|---|---|
| Image quality with the breast-dedicated PET camera | Feasibility of the pilot breast-dedicated PET camera will be assessed on the basis of whether acceptable images are obtained. Images will be assessed and graded as 1 of 3 quality ratings: excellent, good, and poor. The outcome will be reported as the number of images that are excellent, good, and poor, a number without dispersion. | 1 day |
Not provided
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Wendy B DeMartini | Stanford University | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Stanford University | Stanford | California | 94304 | United States |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D001943 | Breast Neoplasms |
| ID | Term |
|---|---|
| D009371 | Neoplasms by Site |
| D009369 | Neoplasms |
| D001941 | Breast Diseases |
| D012871 | Skin Diseases |
Not provided
Not provided
| ID | Term |
|---|---|
| D019788 | Fluorodeoxyglucose F18 |
| ID | Term |
|---|---|
| D003847 | Deoxyglucose |
| D003837 | Deoxy Sugars |
| D002241 | Carbohydrates |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Breast-dedicated PET camera | Device | Breast-dedicated PET camera designed by Stanford satellite radiochemistry facility |
|
| D017437 |
| Skin and Connective Tissue Diseases |